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Abstract
Background: The TH-MYCN transgenic mouse is the most widely used murine model of human neuroblastoma, in which a
human MYCN oncogene is targeted to neuroectodermal cells of developing mice under the influence of the rat tyrosine
hydroxylase promoter. So far, homozygous transgenic mice have been identified by either Southern blot or quantitative real-
time PCR.
Principal Findings: To establish a simple and reliable genotyping method by conventional PCR, we confirmed the
integration of the transgene in the TH-MYCN transgenic mouse by Southern blot and inverse PCR analyses. Our results
showed that either five or six copies were found to be inserted in a head-to-tail tandem configuration at a single locus. The
MYCN transgene/host DNA junction was sequenced and the integration site was identified at chromosome 18qE4. Finally,
we succeeded in designing rapid, simple and reliable genotyping method by common PCR using primers flanking the
integrated TH-MYCN transgene.
Conclusion: We established a simple and reliable genotyping PCR method for determining the integration site of the TH-
MYCN transgene that enables all possible genotypes to be distinguished within several hours. TH-MYCN mice are excellent
model for human neuroblastoma study, thus our results will largely be useful for facilitating the pace of neuroblastoma
study, including in the study of the tumourigenic process, and in the development of therapies to treat patients suffering
from neuroblastoma.
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Introduction
Amplification of MYCN is a genetic abnormality found in
approximately one third of all human neuroblastomas and closely
associated with advanced stage and poor outcome [1,2]. A murine
model of neuroblastoma has been established by targeted
expression of the human MYCN oncogene in neuroectodermal
cells under the control of rat tyrosine hydroxylase promoter (TH-
MYCN) [3]. Use of transgenic mice expressing the human MYCN
oncogene has provided definitive evidence for the role of MYCN
in neuroblastoma tumorigenesis, recapitulating several biological
and histological aspects of clinical neuroblastomas [3,4,5].
There are circumstances where both hemizygous and homozy-
gous transgenic mice are necessary to explore the role of MYCN in
neuroblastomas. So far, homozygous transgenic mice have been
identified by either Southern blot [3] or quantitative real-time
PCR [6]. Quantitative real-time PCR is dependent on the
quantification of differential amounts of transgene DNA between
hemizygous and homozygous transgenic mice, thus, all procedures
should be carried out meticulously with particular attention to the
quality of DNA preparation [6]. Additionally, reliable results of
genotyping may take several days to obtain.
Inverse PCR (IPCR) has numerous applications in molecular
biology including amplification and identification of genomic
inserts [7]. IPCR is generally used if only one internal sequence of
the target DNA is known. It is therefore especially useful in
identifying flanking DNA sequences of genomic inserts. If one or
more of the TH-MYCN transgene/host DNA junctions have been
sequenced, it is convenient to design a PCR to distinguish
homozygotes from hemizygotes. With the aim of facilitating
genotype analysis of TH-MYCN transgenic mice, we analyzed the
arrangement of integrated DNA in transgenic mice by Southern
blot and inverse IPCR analyses.
In this study, we were successful to identify the transgene locus,
in which head-to-tail tandem repeats were integrated at a single
insertion site at chromosome locus 18qE4. Using primers flanking
the integrated TH-MYCN transgene, rapid and reliable genotyping
was achieved by conventional PCR.
Materials and Methods
Mice
129X1/SvJ strain of TH-MYCN transgenic mice [3] were
backcrossed with 129
+Ter/SvJ strain (CLEA, Japan) in our animal
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mice were maintained and used in accordance with guidelines
issued by the Institutional Animal Care and Use Committee.
Genomic DNA preparation
For genotyping PCR analysis [8], 1–2 mm sections of tail tip
were dissolved in 0.1 ml of 50 mM Tris (pH 8.0), 100 mM EDTA,
0.5% SDS, and 0.5 mg/ml proteinase K (Roche) solution at 55uC
for at least one hour with vigorous shaking. The DNA was purified
by phenol/chloroform extraction followed by ethanol precipitation
and then dissolved in 0.5 ml of TE solution. For Southern blot and
inverse PCR analyses, genomic DNA was prepared from digested
liver using DNA Isolation Kit for Cells and Tissues (Roche).
Southern blot
DNA was thoroughly digested with the appropriate restriction
endonucleases. Digested DNA was separated by 1.0% agarose gel
and alkaline transferred to a positively charged nylon membrane
(Roche). DIG-labeled DNA probes were used for Southern blot
analysis (Fig. 1A, 2A) and all procedures for the DIG application
system (Roche) were performed according to the manufacturer’s
recommendations.
Inverse PCR
Genomic DNA digested with PstI restriction enzyme was
separated by agarose gel electrophoresis with molecular weight
marker and the region corresponding to 1.4 kb was cut out. DNA
was eluted using QIAquick Gel Extraction Kit (Qiagen) and self-
ligated with T4 DNA ligase (New England BioLabs) at 16uC over
night. After ethanol precipitation, PCR was carried out using
Advantage cDNA polymerase mix (Clontech) with the following
conditions: 95uC 60 s (1 cycle); 95uC2 0s ,6 8 uC 180 s (35 cycles).
First PCR was performed using primer sets:
OUT2, 59-ACAGAGACACATGACCACACATATATGAG-
GAC-39
IN2, 59-GTCATGATGCTGGTTGAAAGTGGCCTTTG-39
The first PCR product was used for a second nested PCR using
the following primer sets:
OUT1, 59-TTGGCACACACAAATGTATATACACAATGG-39
IN1, 59-AAGACCAAGGATCAGGACACCCCCTAGT-39
Amplified fragments were separated by 1.5% agarose gel
electrophoresis, purified and finally sequenced using OUT1 and
IN1 primers respectively.
Genotyping
PCR was carried out using rTaq (Takara) with the following
conditions: 95uC 60 s (1 cycle); 95uC2 0s ,5 8 uC3 0s ,7 2 uC4 0s
Figure 1. Tandem copies of the transgene are arrayed head-to-
tail at a single insert locus. (A) Schematic diagram of restriction
enzyme sites and the sizes expected by Southern blot analysis. Bold
lines show the position of the probe. B, BamHI; EI, EcoRI;S ,SalI; Xb, XbaI;
Xh, XhoI. (B) Southern blot analysis. Genomic DNA from MYCN
Tg/+
mouse was digested with indicated restriction enzymes. Note that all
results are consistent with the expected size shown in (A). (C)
Quantification of transgene copy number. Genomic DNA (5 mg per
lane) from MYCN
Tg/+ and wild type mice were digested with EcoRI and
SalI. Copy standards were prepared by mixing wild type DNA with a
known amount of DNA and subjected to Southern blot analysis.
MYCN
Tg/+ mouse has about 5–6 copies of the transgene.
doi:10.1371/journal.pone.0006902.g001
Figure 2. IPCR after PstI restriction enzyme digestion. (A)
Restriction enzyme map of PstI and TaqI. PstI and TaqI sites are located
approximately0.7 kband 2.5 kbup-stream ofthe transgene,respectively.
The bold lines indicate location of the 0.7 kb probe. Primers (OUT1 and
IN1) were used for the 2nd IPCR. (B) Southern blot analysis. In addition to
the expected size, an additional band (indicated by arrows) was detected
byPstI(1.4 kb) and TaqI (3.5 kb) digestion. (C) PstIdigested DNA fragment
(1.4 kb) was eluted from the gel, purified and IPCR was carried out. The
expected size (1 kb) of the 2nd PCR product was obtained.
doi:10.1371/journal.pone.0006902.g002
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using Prime STAR Max (Takara) with the following conditions:
98uC 30 s (1 cycle); 98uC1 0s ,6 8 uC 40 s (34 cycles) (Chr18F5/
Chr18R2/hMYCNF). Primers used for the analysis were as
follows, in which OUT1 is listed above:
N008, 59-TGGAAAGCTTCTTATTGGTAGAAACAA-39
N009, 59-AGGGATCCTTTCCGCCCCGTTCGTTTTAA-39
hMYCNF, 59-TCCAGCGAGCTGATCCTCAAACGATG-
CC-39
Chr18F1, 59-ACTAATTCTCCTCTCTCTGCCAGTATTT-
GC-39
Chr18R2, 59-TGCCTTATCCAAAATATAAATGCCCAGC-
AG-39
Chr18F5, 59-ATCTGACATTAAACTTGTGGAGGCCTAG-
AC-39
Results and Discussion
We first determined the integration patterns of transgenes. The
TH-MYCN transgenic vector consists of about 4 kb of rat TH
promoter, 0.7 kb of rabbit b-globin intron, 1.7 kb of human MYCN
cDNA, and 0.1 kb of herpes simplex virus thymidine kinase gene
terminator [3]. Unfortunately, we do not have detailed informa-
tion about the restriction enzyme sites or sequence of the vector. In
spite of this, when multiple copies are present, they are usually
found at a single chromosomal locus [8]. If multiple copies are
integrated in head-to-tail tandem configuration into a single locus
of genome, Southern blot analysis reveals the expected size after
digestion with the appropriate restriction enzyme as shown in
Fig. 1A. The probe used for this experiment corresponds to a
0.7 kb region of rabbit b-globin intron because both rat TH
promoter and human MYCN gene have high homology compared
with their mouse orthologs (more than 80%, data not shown).
Each DNA fragment digested with BamHI (2 kb), XbaI (1.1 kb),
XhoI (1.8 kb), SalI (6.4 kb), EcoRI (4.5 kb), and EcoRI/SalI (0.7 kb)
was consistent with the predicted size (Fig. 1A, 1B). This result
showed that more than 2 copies of transgenes are integrated in
head-to-tail tandem arrays at a single chromosomal locus. We next
examined approximate copy numbers using copy standards. Weiss
et al. estimated that one lineage of TH-MYCN transgenic mice had
about 4 copies of the transgene by Southern blot analysis [3].
Similar to this, our result showed that the estimated copy number
was five to six (Fig. 1C). The widely used murine model for
neuroblastoma is TH-MYCN transgenic mouse established by
Weiss et al. [3], which is currently provided by National Cancer
Institute (NCI). The origin of TH-MYCN transgenic mice in our
facility is derived from NCI. Thus, the TH-MYCN transgenic mice
we used in this study are the same lineage commonly used in
neuroblastoma studies.
IPCR is a method for the rapid in vitro amplification of DNA
sequences that flank a region of known sequence. The individual
digested restriction fragments are self-ligated with a T4 DNA
Figure 3. TH-MYCN transgene is integrated in a Chr18qE4 locus. The sequence of the transgene/host DNA junctions are shown. Bold letters
with underlines indicate the primers (Chr18F5 and Chr18R2) using for genotyping. PstI site is located 610 bp up-stream of the transgene. Dotted lines
indicate 1,063 bp of the genomic DNA deletion. It should be noted that the deletion was shown down-stream of the transgene for convenience (see
results and discussion).
doi:10.1371/journal.pone.0006902.g003
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PCR [7]. To perform IPCR, we first checked whether there are
restriction enzyme sites in the sequences adjacent to the junction.
DNA was digested with several combinations of restriction
enzymes (data not shown) and Southern blot analysis was
performed using a 0.7 kb probe spanning the 59 region of the
rat TH promoter (Fig. 2A). As expected, an additional clear band
was obtained by digestion with either PstI (1.4 kb) or TaqI (3.5 kb)
restriction enzymes (Fig. 2B). In addition, the 1.4 kb band was also
confirmed by PstI and TaqI double digestion (Fig. 2B). This result
suggested that both PstI and TaqI restriction enzyme sites are
mapped to approximately 0.7 kb and 2.5 kb up-stream of the TH
promoter, respectively (Fig. 2B shows as 1.4 kb and 3.5 kb,
respectively). The 1.4 kb of DNA fragment was eluted from the
gel, purified and self-ligated in preparation for IPCR. The 2nd
PCR product obtained as an expected size of 1 kb (Fig. 2C) was
sequenced and referred to genomic BLAST databases.
As shown in Fig. 3, sequencing demonstrated insertion of MYCN
transgene into the E4 locus of chromosome 18q, which is included
in the clone RP24-112L21 (GenBank accession number:
AC118642). It has been reported that the amplification on
chromosome 18 in TH-MYCN transgenic mice was observed by
CGH analysis and suggested that distal chromosome 18 would be
the site of TH-MYCN transgene integration [9]. Consistent with
the previous data, our result proved this by sequencing. Although
the reference sequence is derived from C57BL/6, our sequence
data from both junctions completely matched, additionally PstI
and TaqI restriction sites were also confirmed 0.6 kb (Fig. 2B) and
2.1 kb (data not shown) up-stream of the TH promoter. Moreover,
primers used in this study worked well for genotyping (see below).
Interestingly, a 1 kb deletion of the host genome was observed at
the junction site. Although it is unknown which side of the
transgene contains this deletion, the genomic deletion is shown by
a dotted line at the down-stream of the transgene (Figs. 3). The
sequences of both ends of the transgene were retained (Fig. 3).
Finally, we performed genotyping PCR using flanking primer
sets (Fig. 4A). Fig. 4B shows the results of genotyping of pups
resulting from inter cross mating. Although using primer set
N008/N009, it is possible to distinguish between transgenic and
non-transgenic mice, it is still unknown whether those transgenic
mice are hemizygotes or homozygotes (Fig. 4A and B upper
panel). However, multiple PCR with 3 primers, Chr18F1/
Chr18R2/OUT1 and Chr18F5/Chr18R2/hMYCNF, recogniz-
ing either the 59 or 39 regions of the transgene enables all possible
genotypes to be distinguished by the different size of the products.
The multiple PCR clearly showed wild type (single larger band,
#3 and #6), hemizygous (two bands, #1, #4 and #5), and
homozygous (single smaller band, #2 and #7) transgenic mice
(Fig. 4B middle and lower panels).
In summary, we established a simple and reliable genotyping
PCR method for determining the integration site of the MYCN
transgene. Unlike quantitative real-time PCR, conventional PCR
can be performed with general PCR equipment and materials.
Moreover, easily and immediately determining an accurate
genotype is necessary for facilitating the pace of neuroblastoma
study. Thus, this conventional PCR genotyping method should be
widely used for neuroblastoma study.
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